YOUR STRATEGIC PARTNER IN PROJECT MANAGEMENT: Consulting, Coaching & Training

How cross-functional project-based management improved the performance of pharmaceutical clinical trials at GlaxoWellcome GmbH


Glaxo

The 33rd Global Human Resource Management Conference, Barcelona, 4th – 6th April 2001
In developing a new drug, a pharmaceutical company may invest 500-750mm USD over a seven to ten year development period only to find in clinical trials that the drug is not as
effective as needed to be commercially viable or that another company has already launched a competing drug and will now share the market. Companies who are efficient in taking their new compounds to market as quickly as possible have a business advantage over their competition because first-to-market with an effective treatment quickly converts to market share and profit in the highly competitive, capital intensive pharmaceutical industry. Described in this paper is how cross-functional, project-based management methods were introduced into the clinical trial phase of pharmaceutical new product development at GlaxoWellcome (GW) Germany and its resulting improvement in performance.

Author:

Thomas Johns PhD and Thomas Lander MD

Type:

Articles

Download File:

Article onPM CarreerDevelopment -Glaxo.pdf

Language:

English

Latest From The Twittersphere

Our Clients Just Love Us

  • “The best project management trainers in the US”

    The Director of the NASA Academy , for Project and Program Management Leadership has stated that members of GBMC team are

  • “We found GBMC consultants to be head and shoulders above all other consultants we evaluated in the US.”

    The Director of IT/IS for The State of Oklahoma DHS , has also recently commented

  • “In terms of value for money, (GBMC’s) workshops have been the most successful thing we have done at AIRBUS UK to develop our senior management population”

    The CFO of AIRBUS UK recently commented